Literature DB >> 11096534

Supraventricular Tachyarrhythmia.

.   

Abstract

The main treatment modalities for supraventricular tachycardia are medications and catheter ablation. Ablation is appropriate therapy for paroxysmal supraventricular tachycardia in patients who have a preference for ablation over medications, symptoms that are refractory to medications, severe symptoms, Wolff-Parkinson-White syndrome, or incessant tachycardia. Ablation also is reasonable as first-line therapy in patients with recurrent typical atrial flutter.

Entities:  

Year:  2000        PMID： 11096534     DOI： 10.1007/s11936-996-0003-0

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN： 1092-8464


  21 in total

Review 1.  Optimal management of the patient with an episode of atrial fibrillation in and out of the hospital: acute cardioversion or not?

Authors:  B P Knight; F Morady
Journal:  J Cardiovasc Electrophysiol       Date:  1999-03

2.  Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test.

Authors:  H Calkins; J Sousa; R el-Atassi; S Rosenheck; M de Buitleir; W H Kou; A H Kadish; J J Langberg; F Morady
Journal:  N Engl J Med       Date:  1991-06-06       Impact factor: 91.245

3.  Cost comparison of radiofrequency modification and ablation of the atrioventricular junction in patients with chronic atrial fibrillation.

Authors:  B P Knight; R Weiss; M Bahu; J Souza; A Zivin; R Goyal; E Daoud; K C Man; S A Strickberger; F Morady
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

4.  Electrogram criteria for identification of appropriate target sites for radiofrequency catheter ablation of accessory atrioventricular connections.

Authors:  H Calkins; Y N Kim; S Schmaltz; J Sousa; R el-Atassi; A Leon; A Kadish; J J Langberg; F Morady
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

5.  Comparison of the cost of radiofrequency catheter modification of the atrioventricular node and medical therapy for drug-refractory atrioventricular node reentrant tachycardia.

Authors:  S J Kalbfleisch; H Calkins; J J Langberg; R el-Atassi; A Leon; M Borganelli; F Morady
Journal:  J Am Coll Cardiol       Date:  1992-06       Impact factor: 24.094

6.  Randomized comparison of anatomic and electrogram mapping approaches to ablation of the slow pathway of atrioventricular node reentrant tachycardia.

Authors:  S J Kalbfleisch; S A Strickberger; B Williamson; V R Vorperian; C Man; J D Hummel; J J Langberg; F Morady
Journal:  J Am Coll Cardiol       Date:  1994-03-01       Impact factor: 24.094

7.  Effect of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias.

Authors:  R S Bubien; S M Knotts-Dolson; V J Plumb; G N Kay
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

8.  Analysis of junctional ectopy during radiofrequency ablation of the slow pathway in patients with atrioventricular nodal reentrant tachycardia.

Authors:  J H Jentzer; R Goyal; B D Williamson; K C Man; M Niebauer; E Daoud; S A Strickberger; J D Hummel; F Morady
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

9.  Use of adenosine in patients hospitalized in a university medical center.

Authors:  B P Knight; A Zivin; J Souza; R Goyal; K C Man; A Strickberger; F Morady
Journal:  Am J Med       Date:  1998-10       Impact factor: 4.965

10.  Safety, feasibility and cost of outpatient radiofrequency catheter ablation of accessory atrioventricular connections.

Authors:  S J Kalbfleisch; R el-Atassi; H Calkins; J J Langberg; F Morady
Journal:  J Am Coll Cardiol       Date:  1993-03-01       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.